Suchergebnisse - "Meyer, Antoine"

PubPharm (12)

1

Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis : A Multicentre Cohort Study from the GETAID

enthalten in: Journal of Crohn's & colitis | 2024

von Uzzan, M. | Nachury, M. | Nuzzo, A. | +54

2

Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Meyer, A. | Rios, P. | Drouin, J. | +3

3

Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease : A GETAID multicentre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Fumery, M. | Defrance, A. | Roblin, X. | +22

CommentIn: Aliment Pharmacol Ther. 2023 Apr;57(8):909-910. - PMID 36952268

4

Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis : a GETAID multicentre cohort study

enthalten in: Scandinavian journal of gastroenterology | 2022

von Meyer, A. | Fumery, M. | Peyrin-Biroulet, L. | +22

5

Benefits and Risks Associated With Continuation of Anti-Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease : A Nationwide Emulation Trial

enthalten in: Annals of internal medicine | 2022

von Meyer, A. | Neumann, A. | Drouin, J. | +3

CommentIn: Gastroenterology. 2023 Jun;164(7):1336-1337. - PMID 36608718

6

Serious Infections in Children Born to Mothers With Inflammatory Bowel Disease With In Utero Exposure to Thiopurines and Anti-Tumor Necrosis Factor

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Meyer, A. | Taine, M. | Drouin, J. | +3

7

Systematic review with meta-analysis : the effectiveness of either ustekinumab or vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Parrot, L. | Dong, C. | Carbonnel, F. | +1

8

Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But Not Ustekinumab in Refractory Crohn's Disease

enthalten in: Inflammatory bowel diseases | 2022

von Alric, H. | Amiot, A. | Kirchgesner, J. | +6

9

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF

enthalten in: RMD open | 2022

von Cachen, L. | Nocturne, G. | Collins, M. | +6

10

Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis : A GETAID cohort

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Uzzan, M. | Bresteau, C. | Laharie, D. | +49

CommentIn: Aliment Pharmacol Ther. 2021 Aug;54(3):341-342. - PMID 34236096